NDC 0781-2243
Divalproex Sodium Delayed Release (Sprinkle)
Divalproex Sodium
Divalproex Sodium Delayed Release (Sprinkle) is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc.. The primary component is Divalproex Sodium.
| Product ID | 0781-2243_240e4f6f-a947-a5e6-1267-8627cb8ae755 |
| NDC | 0781-2243 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Divalproex Sodium Delayed Release (Sprinkle) |
| Generic Name | Divalproex Sodium |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-08-31 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA019680 |
| Labeler Name | Sandoz Inc. |
| Substance Name | DIVALPROEX SODIUM |
| Active Ingredient Strength | 125 mg/1 |
| Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |